Search results for "Central Nervous System Agents"

showing 10 items of 18 documents

Small endogenous molecules as moiety to improve targeting of CNS drugs.

2016

A major challenge in the development of novel neuro-therapeutic agents is to effectively overcome the blood-brain barrier (BBB), which acts as a 'working dynamic barrier'. The core problem in the treatment of neurodegenerative diseases is failed delivery of potential medicines due to their inadequate permeation rate. Areas covered: The present review gives a summary of endogenous moieties used in synthesizing prodrugs, derivatives and bioisosteric drugs appositely designed to structurally resemble physiological molecular entities able to be passively absorbed or carried by specific carrier proteins expressed at BBB level. In particular, this overview focuses on aminoacidic, glycosyl, purine…

0301 basic medicinePharmaceutical ScienceEndogenyComputational biologyPharmacologyBlood–brain barrierDiffusion03 medical and health sciences0302 clinical medicinemedicinesmall endogenous moleculesMoietyCNS prodrugAnimalsHumansProdrugsmultifunctional drugbiologyMembrane transport proteinChemistryCNS carrierMembrane Transport ProteinsTranslation (biology)TransporterBiological TransportProdrug030104 developmental biologymedicine.anatomical_structurebioisosteric drugCarrier proteinSettore CHIM/09 - Farmaceutico Tecnologico ApplicativoBlood-Brain Barrierbiology.proteinCarrier ProteinsBBB030217 neurology & neurosurgeryCentral Nervous System AgentsExpert opinion on drug delivery
researchProduct

Efficacy and safety of topiramate in migraine prophylaxis: an open controlled randomized study comparing Sincronil and topamax formulations.

2013

AIM: Topiramate is a small molecule widely used for the treatment of epilepsy, migraine, bipolar disorders and alcoholism, and its availability as a generic formulation could significantly reduce the National Health Service expenditure. A generic formulation, available in Italy under the trademark Sincronil, recently showed superimposable blood levels, after oral administration to healthy volunteers, with the reference formulation. In the present study we report the results of an open label, parallel group, randomized, controlled study performed to evaluate the efficacy, tolerability and impact on disability of two different formulations of topiramate (Sincronil and Topamax) in patients wit…

AdultMaleTime Factorstopiramate migraineAdolescentChemistry PharmaceuticalMigraine DisordersFructoseMiddle AgedSeverity of Illness IndexYoung AdultTreatment OutcomeItalyTopiramateDrugs GenericHumansFemaleAgedCentral Nervous System Agents
researchProduct

In silico prediction of central nervous system activity of compounds. Identification of potential pharmacophores by the TOPS–MODE approach

2004

The central nervous system (CNS) activity has been investigated by using a topological substructural molecular approach (TOPS-MODE). A discriminant analysis to classify CNS and non-CNS drugs was developed on a data set (302 compounds) of great structural variability where more than 81% (247/302) were well classified. Randic's orthogonalization procedures was carried out to allow the interpretation of the model and to avoid the collinearity among descriptors. The discriminant model was assessed by a leave-n-out (when n varies from 2 to 20) cross-validation procedure (79.94% of correct classification), an external prediction set composed by 78 CNS/non-CNS drugs (80.77% of correct classificati…

Central Nervous SystemMolecular modelChemistryStereochemistryIn silicoOrganic ChemistryClinical BiochemistryPharmaceutical ScienceCollinearityComputational biologyLinear discriminant analysisModels BiologicalBiochemistryCross-validationPolar surface areaStructure-Activity RelationshipPredictive Value of TestsDrug DiscoveryMolecular MedicinePharmacophoreMolecular BiologyOrthogonalizationCentral Nervous System AgentsBioorganic & Medicinal Chemistry
researchProduct

The pharmacological and non-pharmacological treatment of attention deficit hyperactivity disorder in children and adolescents: protocol for a systema…

2015

[Background] Attention deficit hyperactivity disorder (ADHD) is one of the most common neurodevelopmental disorders of children and adolescents, with a significant impact on health services and the community in terms of economic and social burdens. The objective of this systematic review will be to evaluate the comparative efficacy and safety of pharmacological and non-pharmacological treatments in children and adolescents with ADHD.

Complementary Therapiesmedicine.medical_specialtyAdolescentPsychological interventionMEDLINEMedicine (miscellaneous)law.inventionAttention deficit hyperactivity disorder03 medical and health sciences0302 clinical medicineClinical ProtocolsRandomized controlled trialCognició en els infantsBehavior Therapylawmental disordersOutcome Assessment Health CareProtocolHumansADHDMedicineAttention deficit hyperactivity disorder030212 general & internal medicineChildPsychiatryChildrenInfants hiperactiusbusiness.industrymedicine.diseaseChiropractic3. Good healthTreatmentClinical trialMeta-analysisSystematic reviewAttention Deficit Disorder with HyperactivityResearch DesignMeta-analysisSystematic reviewbusiness030217 neurology & neurosurgeryCentral Nervous System AgentsSystematic Reviews as TopicSystematic Reviews
researchProduct

Positron emission tomography in CNS drug discovery and drug monitoring.

2014

Molecular imaging methods such as positron emission tomography (PET) are increasingly involved in the development of new drugs. Using radioactive tracers as imaging probes, PET allows the determination of the pharmacokinetic and pharmacodynamic properties of a drug candidate, via recording target engagement, the pattern of distribution, and metabolism. Because of the noninvasive nature and quantitative end point obtainable by molecular imaging, it seems inherently suited for the examination of a pharmaceutical’s behavior in the brain. Molecular imaging, most especially PET, can therefore be a valuable tool in CNS drug research. In this Perspective, we present the basic principles of PET, th…

DrugCentral Nervous Systemmedia_common.quotation_subjectDopamineGlutamic AcidPharmacologyPermeabilityReceptors DopamineDrug DiscoverymedicineAnimalsHumansRadioactive Tracersmedia_commonEnd pointmedicine.diagnostic_testChemistryDrug discoveryDrug candidateTarget engagementBrainModels ChemicalPharmaceutical PreparationsPositron emission tomographyPositron-Emission TomographyReceptors SerotoninSchizophreniaMolecular MedicineMolecular imagingDrug MonitoringGlycolysisBiomedical engineeringCentral Nervous System AgentsJournal of medicinal chemistry
researchProduct

GABA transporters control GABAergic neurotransmission in the mouse subplate.

2015

The subplate is a transient layer between the cortical plate and intermediate zone in the developing cortex. Thalamo-cortical axons form temporary synapses on subplate neurons (SPns) before invading the cortical plate. Neuronal activity within the subplate is of critical importance for the development of neocortical circuits and architecture. Although both glutamatergic and GABAergic inputs on SPns were reported, short-term plasticity of GABAergic transmission has not been investigated yet. GABAergic postsynaptic currents (GPSCs) were recorded from SPns in coronal neocortical slices prepared from postnatal day 3-4 mice using whole-cell patch-clamp technique. Evoked GPSCs (eGPSCs) elicited b…

GABA Plasma Membrane Transport ProteinsGABA Plasma Membrane Transport ProteinsPatch-Clamp TechniquesGABAB receptorBiologyNeurotransmissionSynaptic Transmissiongamma-Aminobutyric acidTissue Culture TechniquesGlutamatergicSubplatemedicinePremovement neuronal activityAnimalsgamma-Aminobutyric AcidGeneral NeuroscienceSomatosensory CortexSynaptic PotentialsReceptors GABA-AElectric StimulationMice Inbred C57BLmedicine.anatomical_structureReceptors GABA-BGABAergicNeurosciencemedicine.drugCentral Nervous System AgentsNeuroscience
researchProduct

Cannabinoid modulation of hippocampal long-term memory is mediated by mTOR signaling.

2009

Cognitive impairment is one of the most important negative consequences associated with cannabis consumption. We found that CB1 cannabinoid receptor (CB1R) activation transiently modulated the mammalian target of rapamycin (mTOR)/p70S6K pathway and the protein synthesis machinery in the mouse hippocampus, which correlated with the amnesic properties of delta9-tetrahydrocannabinol (THC). In addition, non-amnesic doses of either the mTOR blocker rapamycin or the protein synthesis inhibitor anisomycin abrogated the amnesic-like effects of THC, pointing to a mechanism involving new protein synthesis. Moreover, using pharmacological and genetic tools, we found that THC long-term memory deficits …

MaleCannabinoid receptormedicine.medical_treatmentGlutamic AcidHippocampusReceptors N-Methyl-D-AspartateGlutamatergicchemistry.chemical_compoundMiceCognitionReceptor Cannabinoid CB1Memorymental disordersmedicineAnimalsDronabinolPI3K/AKT/mTOR pathwayAnisomycingamma-Aminobutyric AcidMice KnockoutNeuronsProtein Synthesis InhibitorsSirolimusMemory DisordersChemistryGeneral NeuroscienceTOR Serine-Threonine KinasesRibosomal Protein S6 Kinases 70-kDanervous systemKnockout mouseNMDA receptorPhosphorylationCannabinoidNeuroscienceProtein KinasesAnisomycinCentral Nervous System AgentsSignal TransductionNature neuroscience
researchProduct

The hippocampal dentate gyrus is essential for generating contextual memories of fear and drug-induced reward

2008

The hippocampus is believed to play a role in processing information relative to the context in which emotionally salient experiences occur but evidence on the specific contribution of the hippocampal dentate gyrus (DG) to these processes is limited. Here, we have used two classical behavioral paradigms to study the participation of the dorsal DG in context-conditioned reward and context-conditioned fear. Rats received intra-hippocampal vehicle or colchicine injections (4 μg/μl solution; 0.2 μl injections at 10 sites) that damaged the DG but spared other hippocampal subfields. In the first experiment, we used a place conditioning procedure pairing cocaine exposure (20 mg/kg, i.p.) with a sp…

MaleCognitive NeuroscienceConditioning ClassicalHippocampusExperimental and Cognitive PsychologyContext (language use)Hippocampal formationHippocampusBehavioral NeuroscienceCocaineRewardAnimalsRats Long-EvansFear conditioningAnalysis of VarianceDentate gyrusAssociation LearningRetention PsychologyFearConditioned place preferenceRatsDentate GyrusExploratory BehaviorConditioningAnalysis of variancePsychologyNeuroscienceCentral Nervous System Agents
researchProduct

Risk Factors and Number of Falls as Determinants of Quality of Life of Community-Dwelling Older Adults.

2019

Background and purpose In older adults, the psychological impact and effects related to the loss of functional capacity are directly related to perceived quality of life (QOL). The predictors of better QOL are increased physical activity, lower prevalence of overweight, lower cases of depression, and lower rate of reported alcohol abuse. On the contrary, the predictors of decreased QOL are female gender, comorbidity, deficient nutritional condition, polypharmacy, loss of mobility, depression and dependency, poor economic conditions, and social isolation and loneliness. Furthermore, QOL in older adults is more dependent on the number of falls than comorbidity. The objective was to investigat…

MaleCross-sectional studyPoison controlAlcohol abuseComorbidityOverweight03 medical and health sciences0302 clinical medicineQuality of lifeRisk FactorsInjury preventionmedicineHumans030212 general & internal medicineExerciseGeriatric AssessmentAgedPolypharmacyAged 80 and overbusiness.industryDepressionRehabilitationOverweightmedicine.diseaseComorbidityCross-Sectional StudiesQuality of LifeAccidental FallsFemaleIndependent LivingGeriatrics and Gerontologymedicine.symptombusiness030217 neurology & neurosurgeryDemographyCentral Nervous System AgentsJournal of geriatric physical therapy (2001)
researchProduct

Gentamicin alters Akt-expression and its activation in the guinea pig cochlea

2015

Gentamicin treatment induces hair cell death or survival in the inner ear. Besides the well-known toxic effects, the phosphatidylinositol-3 kinase/Akt (PI3K/Akt) pathway was found to be involved in cell protection. After gentamicin application, the spatiotemporal expression patterns of Akt and its activated form (p-Akt) were determined in male guinea pigs. A single dose of 0.1 mL gentamicin (4 mg/ear/animal) was intratympanically injected. The auditory brainstem responses (ABRs) were recorded prior to application and 1, 2 and 7 days afterward. At these three time points the cochleae (n=10 in each case) were removed, transferred to fixative and embedded in paraffin. Seven ears were used as u…

MaleGuinea PigsBiologyAndrologyEvoked Potentials Auditory Brain Stemotorhinolaryngologic diseasesmedicineAnimalsInner earProtein kinase BCochleaPI3K/AKT/mTOR pathwaySpiral ganglionGeneral NeuroscienceAuditory ThresholdAnatomyImmunohistochemistryCochleamedicine.anatomical_structureOrgan of CortiSpiral ligamentsense organsHair cellGentamicinsProto-Oncogene Proteins c-aktCentral Nervous System AgentsNeuroscience
researchProduct